Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Epstein

Showing results (851-860 of 1,132) with videos related to

Pageof 114
Sort By:
The Journal of Urology|May 7, 2013
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillanceJeffrey J Tosoian, Eric JohnBull, Bruce J Trock, et al.
The American Journal of Surgical Pathology|September 25, 2013
GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladderCarla L Ellis, Alex G Chang, Ashley Cimino-Mathews, et al.
The Journal of Urology|November 21, 2017
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active SurveillanceOudai Hassan, Misop Han, Amy Zhou, et al.
The Prostate|December 19, 2007
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentDanil V Makarov, Cameron Marlow, Jonathan I Epstein, et al.
Bulletin of Experimental Biology and Medicine|February 2, 2008
Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 proteinI A Kheifets, Yu L Dugina, T A Voronina, et al.
The Journal of Urology|April 18, 2007
Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsiesD E Hansel, A M DeMarzo, E A Platz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasiaTamara L Lotan, Berrak Gumuskaya, Hameed Rahimi, et al.
Archives of Pathology & Laboratory Medicine|January 13, 2024
Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial CarcinomaGuan-Nan Zhang, Barbara Susnik, Emma J Paulsen, et al.
BJU International|July 30, 2016
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillanceMufaddal M Mamawala, Karthik Rao, Patricia Landis, et al.
Acta Radiologica. Supplementum|January 1, 1986
Carotid bifurcation imaging model for more accurately comparing imaging techniquesS J Zinreich, H Wang, J I Epstein, et al.
Pageof 114

Showing results (851-860 of 1,132) with videos related to

Sort By:
Pageof 114
The Journal of Urology|May 7, 2013
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillanceJeffrey J Tosoian, Eric JohnBull, Bruce J Trock, et al.
The American Journal of Surgical Pathology|September 25, 2013
GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladderCarla L Ellis, Alex G Chang, Ashley Cimino-Mathews, et al.
The Journal of Urology|November 21, 2017
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active SurveillanceOudai Hassan, Misop Han, Amy Zhou, et al.
The Prostate|December 19, 2007
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentDanil V Makarov, Cameron Marlow, Jonathan I Epstein, et al.
Bulletin of Experimental Biology and Medicine|February 2, 2008
Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 proteinI A Kheifets, Yu L Dugina, T A Voronina, et al.
The Journal of Urology|April 18, 2007
Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsiesD E Hansel, A M DeMarzo, E A Platz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasiaTamara L Lotan, Berrak Gumuskaya, Hameed Rahimi, et al.
Archives of Pathology & Laboratory Medicine|January 13, 2024
Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial CarcinomaGuan-Nan Zhang, Barbara Susnik, Emma J Paulsen, et al.
BJU International|July 30, 2016
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillanceMufaddal M Mamawala, Karthik Rao, Patricia Landis, et al.
Acta Radiologica. Supplementum|January 1, 1986
Carotid bifurcation imaging model for more accurately comparing imaging techniquesS J Zinreich, H Wang, J I Epstein, et al.
Pageof 114